MATURE RESULTS FROM A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN PLUS ADRIAMYCIN AND DACARBAZINE WITHOUT RADIATION IN NON‐BULKY LIMITED STAGE CLASSICAL HODGKIN LYMPHOMA

Authors :: E. M. Bengston
Lubomir Sokol
C. M. Bello
S. R. Metzler
B. Shah
Jeremy S. Abramson
Tak Takvorian
Jeffrey A. Barnes
E. Turba
Robert A. Redd
Rosalba Martignetti
Frederick Lansigan
P. Armand
Victoria Patterson
Ann S. LaCasce
Eric N. Jacobsen
Source :: Hematological Oncology. 39
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Limited Stage
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Dacarbazine
Hematology
General Medicine
Internal medicine
medicine
Classical Hodgkin lymphoma
business
Brentuximab vedotin
medicine.drug

Full Text Access

Tools